Transgene Biotek: Board Meeting Outcome for Outcome Of Board Meeting

Dear Sir/Madam This has reference to our letter dated January 28 2026.1) The Board has considered and approved the unaudited Consolidated & Stand-alone Financial Results of the company for the Quarter ended 31.12.2025 in accordance with the Indian Accounting Standards (IND-AS) as per Companies (Indian Accounting Standards) Rules 2015.2) Limited Review Report on the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 31.12.2025 has also been approved.The meeting commenced at 11:00 a.m. and concluded at 11:45 a.m.